NEW YORK (GenomeWeb News) – Fluidigm today said that it has signed an agreement with AH Diagnostics to serve as its exclusive distributor in Sweden, Norway, Denmark, Iceland, and Finland.
Starting Feb. 1, Aarhus, Denmark-based AH will offer Fluidigm's portfolio of BioMark HD, EP1, and Access Array Systems and its arrays for a variety of genomic applications, including the new Deltagene and SNPtype arrays. Financial and other terms of the deal were not disclosed.
"AH diagnostics has built a strong reputation across Scandinavia for addressing the needs of the life science research community," Dominique Remy-Renou, VP of European Commercial Operations for Fluidigm Europe BV, said in a statement. "We look forward to helping them bring the tools needed to solve some of today's most complex genetic questions in biology all the way down to the single cell."